Brochure | July 3, 2020

Kindeva Hollow Microstructured Transdermal System

Source: Kindeva Drug Delivery

Powerful cancer vaccines are one part of the cancer treatment puzzle. Kindeva Hollow Microstructured Transdermal System (hMTS) is designed to help your vaccine reach its treatment potential through intradermal delivery. It’s time to approach clinical trials with confidence.

Why intradermal delivery?

  • Potential for enhanced immune response

Why Kindeva hMTS?

  • Easy, consistent, reproducible intradermal delivery
  • Higher volumes vs. other intradermal delivery devices

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma